Abstract:Osteoarthritis (OA) is a chronic joint disease that seriously jeopardizes human health , primarily characterized by progressive degradation of articular cartilage. However, there is still a lack of effective treatment due to its limited ability to repair cartilage. Paracellularly secreted exosomes , which can participate in a variety of cellular activities, have good therapeutic efficacy in OA. However, the use of natural exosomes alone in the treatment of OA faces problems such as poor joint targeting, short half-life, and poor therapeutic efficacy. A rational pretreatment approach can enhance the targeting, stabilization and in vivo half-life of exosomes for the treatment of OA. In this paper, we review the pre-treatment strategies aimed at enhancing the efficacy of exosomes for OA, in order to provide a scientific basis for the clinical application of exosomes in the treatment of OA.